✦ LIBER ✦

Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency

✍ Scribed by Kirn R. Kessler; Michael Skutta; R. Benecke; for the German Dystonia Study Group

Publisher: Springer
Year: 1999
Tongue: English
Weight: 167 KB
Volume: 246
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s004150050345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety, efficacy, dosing, and

Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia

✍ Brian Berman; Lauren Seeberger; Rajeev Kumar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

## Abstract Short‐term studies of cervical dystonia (CD) have demonstrated botulinum toxin type B (Bot B) to be safe and efficacious at doses of 5,000 to 10,000 units, but few long‐term studies have been published and the safety and efficacy of higher doses has not been established. Additionally, t

Long-term botulinum toxin treatment incr

Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia

✍ Inger Marie Skogseid; Jo Røislien; Bjørgulf Claussen; Emilia Kerty 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract We examined the impact of cervical dystonia (CD) and long‐term botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of long‐term treatment were obtained from 62 CD patients aged 31–66 years (med

Long-term follow-up of cervical dystonia

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A

✍ Peter Haussermann; Stefanie Marczoch; Christiane Klinger; Michael Landgrebe; Bas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

## Abstract We followed the course in 100 consecutive patients with cervical dystonia (CD) after they were initially treated with botulinum toxin (BTX) in the form of Dysport 10 to 12 years ago. A total of 4 patients had died, and 6 were lost to follow‐up. Of the remaining 90 patients, 57 (63%) wer

Predictable variables for short- and lon

Predictable variables for short- and long-term botulinum toxin treatment response in patients with cervical dystonia

✍ Andre C. Felicio; Clecio Godeiro-Junior; Patricia de Carvalho Aguiar; Vanderci B 📂 Article 📅 2009 🏛 Springer Milan 🌐 English ⚖ 142 KB

Treatment of cervical dystonia hand spas

Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin

✍ A. J. Lees; N. Turjanski; J. Rivest; R. Whurr; M. Lorch; G. Brookes 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 525 KB

Comparison of treatment of tardive dysto

Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A

✍ Dr. Allison Brashear; Walter T. Ambrosius; George J. Eckert; Eric R. Siemers 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo